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Background:Mitotic progression is regulated by the spindle assembly checkpoint (SAC) to prevent aneuploidy and chro-
mosome damage.
Results: EDD binds to various SAC components, governs the expression levels of keymitosis-associated proteins, andmediates
the response to the mitotic spindle poison nocodazole.
Conclusion: EDD contributes to the ability of the SAC to mediate checkpoint arrest.
Significance: EDD may act to maintain genomic integrity.
In thiswork,we identify physical and genetic interactions that
implicate E3 identified by differential display (EDD) in promot-
ing spindle assembly checkpoint (SAC) function. During mito-
sis, the SAC initiates a mitotic checkpoint in response to chro-
mosomes with kinetochores unattached to spindle pole
microtubules. Similar to Budding uninhibited by benzimidaz-
oles-related 1 (BUBR1) siRNA, a bona fide SAC component,
EDD siRNA abrogated G2/M accumulation in response to the
mitotic destabilizing agent nocodazole. Furthermore, EDD
siRNA reduced mitotic cell viability and, in nocodazole-treated
cells, increased expression of the promitotic progression pro-
tein cell division cycle 20 (CDC20). Copurification studies also
identified physical interactions with CDC20, BUBR1, and other
components of the SAC. Taken together, these observations
highlight the potential role of EDD in regulating mitotic pro-
gression and the cellular response to perturbed mitosis.
EDD2 (E3 identified by differential display), also known as
UBR5 or hHYD, is an evolutionarily conserved homologous to
E6-AP carboxyl terminus bearing E3 ubiquitin-protein ligase of
theN-rule pathway (1) and homolog ofDrosophila hyperplastic
discs (Hyd), a Drosophila tumor suppressor involved in con-
trolling tissue growth and differentiation (2–4). Evidence to
support a conserved role for the human homolog in tumorigen-
esis comes from its high mutational frequency in diverse can-
cers (COSMIC, Wellcome Trust Sanger Institute), with a par-
ticular high incidence in breast (5) and mantle cell carcinoma
(6).
Although implicated in DNA damage-mediated control of
cell cycle progression (7–10), EDD has not yet been associated
with SAC-associated regulation of mitosis. The SAC is a multi-
protein complex that comprises mitotic arrest deficient 2
(MAD2), Bub1-related protein kinase (BUBR1), and budding
uninhibited by benzimidazoles 3 (BUB3). Acting together, they
provide an essential mitotic checkpoint that maintains chro-
mosomal integrity, ensures correct chromosome separation,
and prevents aneuploidy (11). Triggered by kinetochores unat-
tached to the mitotic spindle, activation of the SAC delays
metaphase-anaphase transition to allow Aurora B kinase-me-
diated error correction mechanisms to promote kinetochore
attachment (12–14). Mechanistically, the SAC achieves the
temporal delay in anaphase progression by inhibiting cell divi-
sion cycle 20 (CDC20), a substrate specificity factor for themul-
tisubunit E3 APC/C (11). SAC-associated CDC20, collectively
referred to as themitotic checkpoint complex (MCC), is unable
to promote APC-mediated degradation of metaphase-to-ana-
phase inhibiting proteins such as Cyclin B and Securin (11).
Here we identify physical interactions between EDD, CDC20,
and components of the SAC and reveal the potential role of
EDD promoting mitotic arrest in response to Noc.
EXPERIMENTAL PROCEDURES
Plasmids, siRNA Oligos, and Transfections—The EDD,
BUB3, and BUBR1 coding sequences were amplified by PCR
from HeLa total cDNA and cloned into a modified
pcDNA5/FRT (Life Technologies) containing an amino-ter-
minal 2HA/2Strep (HS) or V5/FLAG (VF) epitope tags.
Plasmid transfectionswere performedusing Effectene (Qiagen)
according to the protocol of the manufacturer or with the
N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic acid/CaCl2
method (Life Technologies). EDD and BUBR1 were silenced
using Lipofectamine RNAiMax (Life Technologies) with the
following oligos: siEDD1, 5-CTCGTCTTGATCTACTT-
TATC-3; siEDD2, 5-GUGUAUCAGUUUGCUUUCCAA-3;
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scramble control, 5-GAACCAAAGUAGCAUAUAACU-3;
and siBUBR1, 5-CAUAUUCAAAUGCCCGUU-3.
Cell Culture and Nocodazole Treatment—An inducible
HEK293 cell line expressing HS-EDD was created using
FLP-InTM HEK293 T-REx (Life Technologies). HEK293 and
HeLa cells were grown at 37 °C/5%CO2 in high-glucoseDMEM
(Sigma) supplemented with 10% FBS (Life Technologies) and 4
mM L-glutamine (Sigma). HeLa cells were arrested in mitosis by
treating themwith either 50 ng/ml nocodazole or 10 nMTaxol for
18 h.Mitotic cells were harvested by a physical “shake-off.”
Pulldown Assays, Immunoprecipitation, Immunoblotting,
and Mass Spectrometric Identification—Transfected HS-EDD
HEK293 were induced with 1 mg/ml doxycycline for 4 h before
harvesting. Cells were then washed once in ice-cold PBS and
lysed with Triton lysis buffer (50 mM Tris (pH 7.5), 100 mM
NaCl, 2mMEDTA, 1%Triton X-100, 1Roche protease inhib-
itor mixture, and 1 Roche phosphatase inhibitor mixture).
The lysates were clarified by centrifugation at 13,000 rpm for 15
min at 4 °C in a benchtop rotor. V5/FLAG-BUB3 was pulled
down using FLAG-M2 beads (Sigma) for 1 h at 4 °C. Beads were
washed three times with lysis buffer, and protein complexes
were eluted with 1 bead volume of 1 Laemmli sample buffer
with 5% -mercaptoethanol. To immunoprecipitate endoge-
nous BUB3 and BUBR1, cells were lysed as above and pre-
cleared using appropriate isotype IgG-conjugated beads (Cell
Signaling Technology) for 45 min at 4 °C and then incubated
with the appropriate antibody overnight at 4 °C. Samples were
then incubated with the appropriate IgG F(ab’)2-conjugated
beads (Cell Signaling Technology) for 30 min at 4 °C, spun
down, and eluted with 1 bead volume of 1 Laemmli sample
buffer. Precast NuPAGE BisTris gradient gels (Life Technol-
ogies) were used for SDS-PAGE, run with MOPS buffer, and
semidry-transferred onto PVDF prior toWestern blot analysis.
Antibodies used were as follows: mouse FLAGM2 (Sigma, cat-
alog no. F3165); rabbit FLAG M2 (Sigma, catalog no. F7425);
goat EDD M19 (Santa Cruz Biotechnology, catalog no.
sc-9561); mouse CDC27/APC3 (Abcam, catalog no. ab10538);
rabbit CDC20 (Santa Cruz Biotechnology, catalog no. sc-8358);
mouse p21 (Santa Cruz Biotechnology, catalog no. sc-6246);
mouse BUB3 (catalog no. BD 611730); rabbit BUBR1 (Bethyl,
catalog no. A300-386A); sheep BUBR1 (a gift fromDr. Stephen
Taylor, University ofManchester); and anti-rabbit, anti-mouse,
and sheep IgG HRP-linked secondary antibody (Cell Signaling
Technology).
For the mass spectrometry studies, lysates from four 15-cm
plates ofHS-EDDorHS tagHEK293 cells were tandemaffinity-
purified by HA and Streptactin-based affinity resins (Invitro-
gen). Purified proteins were separated into high and lowmolec-
ular weights by SDS-PAGE, in-gel digested using trypsin, and
fractionated using strong cation exchange. Fractions were
desalted and analyzed using LC-MS on a LTQ-Orbitrap
(ThermoFisher Scientific) coupled toHPLC.TheMSdatawere
analyzed using MaxQuant, and proteins were identified by
searching MS and MS/MS data using the MASCOT search
engine.
Live Imaging—HeLa cells expressing red fluorescent protein-
tubulin (RFP-tubulin) andGFP-histone H2B (15) were silenced
with siRNAs using Lipofectamine RNAiMAx (Life Technolo-
gies). 48 h after transfection, cells were placed in complete
DMEM without phenol red in a temperature- and CO2-con-
trolled incubation chamber (Solent Scientific Ltd), and images
were acquired every 10 min using a Nikon Ti Eclipse inverted
microscope, a Nikon 10 Plan Fluor 0.3 numerical aperture
Ph1 lens, and Nikon fluorescence filter sets for GFP and RFP
(NikonUK Ltd). Image acquisition was performed using a Pho-
tometrics Coolsnap HQ2 charge-coupled device camera (Pho-
tometrics Ltd) and Nikon Nis-Elements advanced research
software (Nikon Instruments Europe). A combination of
brightfield, RFP-tubulin, and GFP-H2B images was used to
determine cells entering mitosis, progressing, exiting mitosis,
and undergoing cell death. Using these criteria, we were able to
determine the total number of cells attempting mitosis over a
10-h time course separated into 10-min time frames. Cells
termed “successfully completing mitosis” entered, progressed,
and exited mitosis without exhibiting any defects. Cells initiat-
ing mitosis and either exhibiting cell death within or shortly
after mitosis or failing to complete cytokinesis were deemed to
be cells attempting but failing to successfully complete mitosis.
FACS Analysis—For FACS analysis, silenced HeLa cells were
washed once with PBS, fixed with ice cold 70% EtOH, and
stainedwithDAPI (1:2500). Anti-H2AX antibody (catalog no.
05-636, Millipore) was used for DNA damage studies and ana-
lyzed according to Huang and Darzynkiewicz (16) without cell
cycle phase determination. Samples were analyzed using a BD
FACS Aria III and FACSDiva software (BD Biosciences).
Immunofluorescence—HeLa cells seeded on coverslips were
washed with PBS and fixed in 4% paraformaldehyde:PBS for 10
min at room temperature. After washing with PBS, cells were
permeabilized using 0.25% Triton X-100:PBS for 5 min,
blocked in 10% BSA:PBS for 30 min, and incubated with the
appropriate primary antibodies at 4 °C overnight. Antibodies
used were as follows: rabbit EDD (Bethyl, catalog no. IHC-
00025); mouse BUB3 (catalog no. BD 611730); and sheep
BUBR1 (a gift fromDr. Taylor, University ofManchester). After
washing with PBS, cells were incubated for 30 min at room
temperaturewith the appropriate fluorescently conjugated sec-
ondary antibody (488-sheep A11015, 488-mouse A21202, and
594-rabbit A21207; Life Technologies) and mounted in
Vectashield containing DAPI (Vector Laboratories, Inc.). All
antibodies were diluted in blocking solution. Images were cap-
tured on a Zeiss Axioplan II fluorescence microscope and ana-
lyzed using the Volocity software (PerkinElmer Life Sciences).
Graphing, Statistical, and Image Processing Software—
Microsoft Excel and GraphPad Prism were used to produce
graphs and carry out statistical analyses. Adobe Photoshop and
Illustrator were used to manipulate the images and lay out the
figures, respectively.
RESULTS
EDD Complexes with the SAC Components BUB3 and
BUBR1—To identify new interactors of the 309-kDa EDD pro-
tein, we created a stable doxycycline-inducible HS-tagged EDD
(HS-EDD) HEK293 cell line using site-specific recombinase
FLP-mediated recombination. Mass spectrometry of purified
HS-EDD-complexed proteins revealed the mitotic checkpoint
protein BUB3 to be a potential novel interactor (Fig. 1A).
EDD InfluencesMitosis
12586 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 20•MAY 15, 2015
 at U
niversity of Edinburgh on M
ay 22, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Encouragingly, we also identified Xaa-Pro aminopeptidase 3, a
previously identified EDD interactor (17). To verify the BUB3
interaction, we performed co-IP studies in asynchronous
HEK293 cells, which confirmed an interaction between exoge-
nous FLAG-BUB3 and both endogenous EDD and exogenous
HS-EDD (Fig. 1B). Because of the role of BUB3 in the SAC, we
addressedwhether EDDcould also bind toBUBR1. IP of endog-
enous BUBR1 from asynchronous HeLa cells co-IPd both
endogenous EDD and BUB3 (Fig. 1C, left panel). To examine
the interaction profile of EDD in mitotic cells with an activated
SAC, we performed BUBR1 co-IP studies with HeLa cells
treated with the microtubule poison agent Noc (18) or the
microtubule-stabilizing agent Taxol (Tax) (19) (Fig. 1C, center
and right panels, respectively). In comparison with untreated
asynchronous cells, both spindle poisons resulted in a small, but
reproducible, reduction in co-IPd EDD. However, there was no
reduction in the interaction between BUBR1 and BUB3, sug-
gesting that the interaction of EDD with BUBR1may preferen-
tially occur either outside ofmetaphase and/or in the absence of
spindle poisons.
EDD Complexes with MCC- and APC/C-associated Factor
CDC20—The ability of EDD to bind BUBR1 and BUB3 sug-
gested that it might influence the formation or stability of the
SAC and/or the CDC20-containing MCC. To address this, we
carried out co-IP studies in twodifferent cell lines (Fig. 2).Using
asynchronous HeLa cells, we first addressed whether EDD
siRNAwould affect the interaction of BUBR1 with endogenous
CDC20 and BUB3 (Fig. 2A). Comparison of BUBR1 IPs from
scrambled siRNA-treated (control) and EDD siRNA-treated
HeLa cells revealed no differences in the amount of coimmu-
noprecipitated CDC20 or BUB3. Of note, EDD siRNA did not
affect BUBR1 or BUB3 expression levels in the input lysates.
Consistently, EDD siRNA in both cell lines resulted in a small
decrease in the CDC20 inputs that accompanied a decrease the
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FIGURE 1. EDD coimmunoprecipitateswith BUB3 andBUBR1. A, MS/MS-based identification of HS-EDD copurifying proteins fromHEK293 cells (n 3). Any
HS-EDD copurifying proteins identified in the HS-only sample were removed for the HS-EDD potential interactor list. The five top hits are shown and include
the EDD bait, two mitochondrial proteins (MRS2 and C1QBP), BUB3, and Xaa-Pro aminopeptidase 3. B and C, HEK293 (B) and HeLa cells (C) were either
transfected with the indicated constructs (B) or treated with either Noc or Tax (C) prior to IP with the indicated antibodies or IgG controls (Ctrl). Lysates (Input)
and coimmunoprecipitates were analyzed by SDS-PAGE andWestern blotting with the indicated antibodies. Quantification of immunoprecipitated EDD in C
indicated a 69% and 81% reduction upon nocodazole and Taxol treatment, respectively. Images are representative of two independent experiments. Molec-
ular weight standards are indicated. Note that EDD is 309 kDa and runs well above the high molecular weight marker (250 kDa).
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amount of IPd CDC20. Concurrently, a similar reduction was
also observed with coimmunoprecipitated BUBR1 and BUB3.
Overall, the effects observed in HeLa cells were very similar to
those observed in HCT116 cells (Fig. 2B), with EDD siRNA
reducing CDC20 expression in the lysate. In summary, EDD
siRNA appeared to affect CDC20, but not BUBR1 complexes.
The Subcellular Localization of EDD Changes through Mito-
sis andColocalizes with BUB3—Because of the ability of EDD to
bind SAC components, we wished to establish the mitotic sub-
cellular localization of EDD and its ability to colocalize with
chromosomes, BUB3 and BUBR1. Previous reports have
revealed EDD to be a nuclear protein (20–22). However, its
specific expression through mitosis was not determined. Using
immunofluorescence, we revealed EDD to be present in small
puncta throughout the cell in prophase, prometaphase, and
metaphase (Fig. 3, A’–C’, arrows). During anaphase, EDD sig-
nals formed larger puncta that appeared to be excluded from
the chromosomes (Fig. 3D’, dashed lines). Intriguingly, during
late anaphase (anaphase II), the pattern observed in early ana-
phase was reversed, with EDD puncta almost exclusively colo-
calizing with the chromosomes (Fig. 3E’’). As telophase pro-
gressed, EDD signal localization became more diffuse and less
concentrated on chromosomes (Fig. 3,F’’ andG’’,arrows).Non-
mitotic interphase cells demonstrated strong nuclear EDD
staining punctuated with weak staining within regions of low
DAPI intensity (presumed nucleoli, Fig. 3, G–G’’, arrowheads).
In comparison with telophase and interphase cells, EDD signal
intensity was reduced during prophase to anaphase (Fig. 3A’,
compare interphase (arrowhead) and prophase (arrow) cells).
In light of the physical interactions of EDD with BUBR1 and
BUB3, we wished to determine its ability to colocalize with
them (Fig. 3, H–L’’’ and M–Q’’’). Throughout mitosis, BUB3
(Fig. 3, N–Q’’’), but not BUBR1 (Fig. 3, I–K’’’), showed very
similar expression patterns as EDD. In interphase, the nuclear
localization of EDD overlapped with BUBR1 cell-wide- and
BUB3 nuclear expression patterns (Fig. 3, H’’’ and M’’’, respec-
tively). During prophase, EDD signals failed to significantly
overlap with the predominantly perinuclear and cytoplasmic
staining of BUBR1 (Fig. 3I’’’). Similarly, during prometaphase
and metaphase, BUBR1 and EDD puncta failed to significantly
colocalize, with BUBR1 signals preferentially colocalizing with
DAPI (Fig. 3K’’), indicative of its association with kinetochores
(23). The region of intense BUBR1 signal also corresponded
with a region of lowEDDsignal (Fig. 3K’,dashed line). Daughter
cells undergoing cytokinesis revealed EDD to be associated
with nuclei, potential micronuclei (Fig. 3, L, inset, and L’, inset,
open arrowhead), and the cytokinetic neck/junction, an area
that lacked a DAPI signal (Fig. 3, L, inset, and L’, closed
arrowheads).
In contrast with BUBR1, BUB3 was nuclearly localized in
interphase (Fig. 3M’’) and evenly distributed across the cell dur-
ing prometaphase (Fig. 3O’’). As with EDD, BUB3 appeared to
be excluded from the DNA during metaphase and telophase
(Fig. 3, P’’ and Q’’, respectively, dashed lines). Therefore, EDD
exhibited strong colocalization with BUB3 throughout mitosis
and weaker colocalization with BUBR1 during interphase and
prophase. These observations may also help to explain why less
EDD was coimmunoprecipitated with BUBR1 upon Noc- or
Tax-mediated enrichment of metaphase cells (Fig. 1C). Taken
together, these data suggest that the physical interaction
between EDD and BUBR1, but not BUB3, may be regulated by
subcellular compartmentalization/sequestration.
EDD siRNA Abrogates G2/M Arrest in Response to Noc
Treatment—Because of the ability of EDD to associate with
SAC/MCC components, we hypothesized that it may also gov-
ern amitosis-associated response toNoc treatment. To address
this, HeLa cells were first treated with scrambled, EDD, or
BUBR1 siRNAs, followed by Noc treatment and FACS analysis.
Examination of the EDD- and BUBR1 siRNA-treated cells
revealed a visible decrease in the appearance of rounded cells in
comparison with the scrambled control (Fig. 4A). In compari-
son with the scrambled siRNA-treated cells, FACS analysis
revealed the expected BUBR1 siRNA-mediated reduction in
the number of G2/M cells (Fig. 4B), reflecting the reported
impairment of SAC function and an inability to arrest in M
phase (23). Similarly, BUBR1 siRNA cells showed an increased
G1 cell population, whichwas presumably due to a combination
of increased cellular flux ofG2/Mcells intoG1 and/or activation
of theG1 checkpoint as a consequence of themitosis-associated
chromosomal defects and DNA damage (24). A similar overall
cell cycle profile was also observed in EDD siRNA cells. How-
ever, the effects on theG1 andG2/Mcell populationsweremore
pronounced (Fig. 4B). Importantly,Western blot analysis of the
siRNA-treated cells revealed the expected siRNAi-mediated
knockdown of their appropriate targets (Fig. 4C). Therefore,
both BUBR1 and EDD siRNA cells exhibited decreased G2/M
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FIGURE 2. EDD coimmunoprecipitates with SAC- and APC-associated components. A and B, HeLa (A) and HCT116 (B) cells were treated with either EDD or
scramble control siRNAs. Following siRNA treatment, lysates were immunoprecipitated with CDC20, BUBR1, or IgG control (Ctrl) antibodies, and coimmuno-
precipitating proteins were analyzed by SDS-PAGE and Western blotting with the indicated antibodies. Ponceau Red-stained membranes are included as a
loading control for the lysate inputs. Images are representative of two independent experiments.
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and increased G1 cell populations in response to Noc treat-
ment. Interestingly, combined EDD siRNA and BUBR1 siRNA
resulted in a more pronounced cell cycle profile than that of
EDD siRNA alone. This additive effect between EDD and
BUBR1 siRNA, combined with the physical association
between the two proteins, suggests that theymay both function
to normally promote a G2/M arrest and suppress G1 arrest in
response to Noc. EDD siRNA treatment also caused a similar
cell cycle profile in response to Taxol treatment (Fig. 4D).
EDD Represses BUBR1, APC3, and CDC20 Expression in
Mitosis—Next, to gain insight into the potential mechanism
underlying EDD siRNA abrogation of the Noc-mediated G2/M
accumulation, we examined the mitotic expression of key
mitotic regulators. HeLa cells were treated with Noc, and
mitotic cells were shaken off, replated, and then allowed to pro-
gress through mitosis in Noc-free medium. Cells were har-
vested at various time points following Noc release and ana-
lyzed byWestern blotting (Fig. 4E). In scramble siRNA-treated
cells, BUBR1 and CDC20 levels decreased steadily as mitosis
progressed, as did the phosphorylated form of the APC subunit
APC3, a marker of APC activity (25). In contrast, BUB3 and
EDD expression levels remained relatively constant. In com-
parison, cells treated with two independent EDD siRNAs
(siEDD-1 and siEDD-2) exhibited dramatically increased
expression levels of BUBR1, phospho-APC3, and CDC20.
However, 180 min after Noc release, at a time when HeLa cells
have exitedmitotic arrest and begin cycling (26), the expression
levels of all analyzed proteins decreased to control levels. Den-
sitometric analysis (Fig. 4F) confirmed BUBR1, phospho-
APC3, and CDC20 expression levels to be increased (BUBR1,
5-fold; phospho-APC3,3-fold; CDC20,2-fold) over con-
trol levels. Therefore, upon impairment of EDD function,
mitotic cells overexpress CDC20 and phospho-APC3, two pos-
itive regulators of APCCDC20-associated mitotic progression
(27).
EDD siRNA Does Not Regulate “Normal” Mitotic Duration—
Although all SAC components govern mitotic arrest in
response to microtubule poisons, only BUBR1 andMAD2 gov-
ern the duration of normal mitoses (15), a process termed
“mitotic timing.” The ability of EDD to associate with BUBR1
prompted us to address whether EDD siRNAwould behave like
BUBR1 and affect normal mitotic timing (15). Using live cell
imaging and time-lapse microscopy of HeLa cells stably
expressing RFP-tubulin GFP-histone H2B (15), we scored for
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successful and unsuccessful (i.e. dying within or soon after
mitosis, exhibiting abnormal/multipolar spindles or failed/ab-
normal cytokinesis) mitoses and the duration of successful
mitoses (see “Experimental Procedures” for details). The anal-
ysis revealed that, in comparison with scrambled siRNA treat-
ment, EDD or BUBR1 siRNA reduced both the number of
attempted (Fig. 5A) and successful (Fig. 5B) mitoses, but only
BUBR1 reduced mitotic timing (Fig. 5C). Western blot analysis
confirmed the efficient knockdown of the target proteins (Fig.
5D). Closer analysis of cells attempting mitosis revealed EDD,
but not BUBR1, siRNA to increase cell death (Fig. 5E). How-
ever, statistical analysis indicated that the effects were not sig-
nificant (p 0.1). However, focusing on cell death events solely
occurring within mitosis (Fig. 5F), but not after mitosis (Fig.
5G), revealed that EDD siRNA increased the frequency (p 
0.05). Analysis of cytokinesis also revealed that BUBR1, but not
EDD, siRNA resulted in cytokinesis defects associated with
incomplete cellular fission and subsequent fusion of the daugh-
ter cells (p 0.001).
In conclusion, EDD and BUBR1 siRNA both resulted in a
significant reduction in the frequency and success rate of mito-
sis. However, EDD siRNA did not affect mitotic timing but did
increase the amount of mitosis-associated cell death.
EDD and BUBR1 siRNA Increase  H2AX Levels—To inves-
tigatewhatmight be responsible for the increased cell death, we
looked for signs of DNA damage. The SAC aims to delay
mitotic progression to prevent improper chromosome distri-
bution and DNA damage associated with damaged lagging
chromosomes (28) and telomere exposure (29). Aberrant SAC
behavior results inmitosis-associatedDNAdamage that subse-
quently leads to p53-mediated G1 arrest in daughter cells (30,
31). To address whether EDD siRNA also resulted in DNA
damage, we used FACS to detect changes in the expression
levels of a H2AX, a marker of double strand breaks (Fig. 6A).
Both EDD and BUBR1 siRNA resulted in a significant increase
in H2AX levels in comparisonwith a scrambled control. How-
ever, FACS analysis by propidium iodide staining revealed that
only BUBR1 siRNA caused a significant increase in the G1 cell
population in comparison with the control (Fig. 6B). Interest-
ingly, Western blot analysis of EDD siRNA-treated cells
revealed a moderate increase the expression of p21 (Fig. 6C), a
CDK inhibitor and potent mediator of the G1/S checkpoint
(32). Interestingly, cells transfected with both EDD and BUBR1
siRNAs resulted in a FACS profile very similar to that ofBUBR1
siRNA alone (Fig. 6C). In conclusion, even though EDD siRNA
increased H2AX and p21 expression levels, it did not mediate
an accumulation of G1 cells.
DISCUSSION
In this study, we reveal the ability of EDD to govern the cel-
lular response to a mitotic spindle poison (Noc), document the
dynamic relationship of EDD with mitotic chromatids/chro-
mosomes during mitosis (Fig. 2), and support the mass spec-
trometry-based observations that identified the association of
EDD with mitotic chromosomes (33). Furthermore we also
identified novel physical and genetic interactions between EDD
and BUBR1 as well as the ability of EDD to suppress CDC20
expression. Taken together, our results suggest that EDD may
promote SAC function in response to dramatic spindle
perturbations.
Both EDD andBUBR1 siRNAprevented the accumulation of
G2-Mcells in response toNoc treatment, supporting the poten-
tial role of EDD as positive regulator of a G2/M or M-phase
checkpoint. Interestingly, combinedEDD andBUBR1 siRNAof
Noc-treated cells revealed a more dramatic effect than single
treatment alone. This observation, in combination with the
ability of the two proteins to copurify, suggests that the two
proteinsmightwork together in the samepathway, althoughwe
are unable to rule out the participation of EDD in a BUBR1-
independent parallel pathway.
In the presence of Noc, mitotic cells normally undergo pro-
longed activation of a SAC-mediated mitotic arrest caused by
SAC-mediated inhibition of CDC20 function (27). Noc-treated
mitotic EDD siRNA cells exhibited dramatically increased lev-
els of both CDC20 and the CDC20-binding competent, phos-
phorylated, and active form of APC3 (Fig. 4D), indicative of
increased APCCDC20 activity (25). This suggests that EDD, like
BUBR1 and BUB3, normally acts to repress CDC20 function.
Identification of the physical association of EDD with CDC20
and APC3 provides a potential direct molecular mechanism by
which EDD, an E3 enzyme, may promote their ubiquitin-de-
pendent degradation. CDC20, as part of the MCC, is ubiquity-
lated and degraded in an APC/C-dependent manner (34, 35).
The ability of EDD to complex with CDC20, BUBR1, and BUB3
supports the idea that EDD could promote APCMCC-mediated
CDC20, and potentially APC3, degradation.
The accompanying increase in BUBR1 expression upon EDD
siRNA also suggests that EDD affects the expression of SAC
components during mitosis. As with CDC20, EDD may influ-
ence APC-mediated BUBR1 ubiquitylation and degradation
(36). Increased p53-mediated transcriptional up-regulation of
BUBR1 (37) could also account for the observed increase in
BUBR1 expression in EDD siRNA cells. Our observation of
EDD siRNA increasing the expression p21, the product of one
of the target genes of p53, provides evidence for increased p53
activity in EDD siRNA cells. Interestingly, the increase in
BUBR1 expression did not appear to correlate with increased
SAC activity, as determined by the failed accumulation of a
G2/M cell in response to Noc. Therefore, we predict that
althoughEDDmaynormally suppresses the expression levels of
BUBR1, it may also positively regulate the activity of BUBR1.
Alternatively, EDDmay only suppress the expression of certain
subcellular pools of BUBR1 not incorporated into SAC or
FIGURE 4. EDD siRNAabrogates nocodazole-mediatedG2/Maccumulation and increases expression of CDC20, phospho-APC3, andBUBR1.HeLa cells
were treated with the indicated siRNAs, treated with nocodazole (A–C, E, and F) or Taxol (D) for 18 h, released, and imaged by brightfield microscopy (A) and
analyzedbypropidium iodide stainingandFACSanalysis (BandD, respectively). siRNAefficiency (C) and siRNA-treatedcells released fromNoc for the indicated
times post-release (E) were analyzed by SDS-PAGE andWestern blotting with the indicated antibodies. F, density quantification of bands in E, with the values
expressed relative to scrambled siRNA t0 values. The data in B and Dwere analyzed using one-way analysis of variance and Tukey’s multiple comparison test,
which revealed all G1 or G2/M comparisons to be significantly different.
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MMC complexes. Unlike BUBR1 and CDC20, BUB3 expres-
sion levels did not change through mitosis or upon EDD/
BUBR1 siRNA. A lack of rapid BUB3 protein turnover could
reflect its non-catalytic scaffolding role within the SAC.
The potential ability of EDD to influence SAC and
APCCDC20/MCC function provides a potent means of regulating
mitotic progression as well as DNA damage associated with
improper/untimely mitosis (24). The increased p21 expression
sc
ra
m
bl
e
EDD
BubR1
Bub3
Loading control
si
ED
D
_1
si
Bu
bR
1
si
ED
D
_2
DC
E F
G H
0
20
40
60
80 0.1021
%
 M
ito
tic
 C
el
ls
Con EDD BUBR1
Mitotic Death
0
10
20
30
40
50
0.0450
%
 M
ito
tic
 C
el
ls
Con EDD BUBR1
Death During
0
5
10
15
20
0.8704
%
 M
ito
tic
 C
el
ls
Con EDD BUBR1
Death After
0
10
20
30
40 < 0.0001
%
 M
ito
tic
 C
el
ls
Con EDD BUBR1
Cytokineses Defects
0
20
40
60
< 0.0001
%
 T
o
ta
l C
el
ls
Conv EDD-1 EDD-2 BUBR1
Successful Mitosis
0
2
4
6
8
N
o 
of
 F
ra
m
e
s
Con EDD-1 EDD-2 BUBR1
Length of Mitosis
0
20
40
60
80
< 0.0001
%
 To
ta
l C
el
ls
Con EDD-1 EDD-2 BUBR1
Attempted Mitosis
FIGURE 5. EDD siRNA reducesmitotic frequency and success rate, but notmitotic timing. A–C, asynchronous HeLa cells were treated with EDD, BUBR1, or
scrambled control (Con) siRNAs for 12 h prior to time-lapse microscopy. Cells were scored for their ability to initiate (A) and successfully complete mitosis (B),
and we measured the duration of those successful mitoses (C). D, SDS-PAGE and Western blotting with the indicated antibodies validated the efficacy of
siRNA-mediated knockdown. E–H, the fate of cells attempting mitosis was also assessed for overall cell death (E), death during mitosis (F), death following
mitosis (G), and abnormal cytokinesis (e.g. fusion of daughter cells) (H). The total number of cells analyzed was 100 and, for mitotic cells, 40 for all
siRNA-treated cell groups. The data in A, B, and E–Hwere analyzed by Fisher’s exact test with the p value indicated, whereas the data in Cwere analyzed using
one-way analysis of variance and Tukey’s multiple comparison test, which revealed a significant difference between BUBR1 siRNA and the other three siRNA
treatments. E–H incorporate pooled data from siEDD-1 and siEDD-2. Errors bars represent mean S.D.
EDD InfluencesMitosis
12592 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 20•MAY 15, 2015
 at U
niversity of Edinburgh on M
ay 22, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
levels in EDD siRNA cells may reflect an attempted p53-medi-
ated cell cycle arrest in response to the concomitant increase in
H2AX DNA damage signals. Supporting these observations,
EDD has been proposed to be a negative regulator of p53 activ-
ity and suppressor of a G1 cell cycle arrest (9, 10). The absence
of such an arrest in HeLa cells may potentially be explained by
their expression of HPV E6, a potent inhibitor of p53 function
(38).
Although EDD siRNA alone did not induce G1 arrest, in the
presence of Noc, both EDD and BUBR1 siRNAs caused a dra-
matic increase in the G1 cell population. Therefore, Noc treat-
ment appeared to uncover the role of EDD in suppressing a G1
arrest. The ability of Noc to increase DNA damage signaling
(24), particularly at telomeres (39), may provoke a robust DNA
damage response (DDR) that is normally held in check by EDD.
Such a role for EDD is supported by its ability to suppress DDR
signaling at sites of DNA damage (40) and, specifically, at
exposed telomeres (41). The role of EDD in suppressing an
inappropriate DDR from exposed telomere endsmay be partic-
ularly relevant because of the ability of mitotically associated
Aurora-B-kinase to promote telomere-associated DDRs (29).
Previously, the SAC-regulated mitotic checkpoint and the
G1/S DNA damage checkpoint were thought to function inde-
pendently of each other. Recent evidence revealed that ataxia
telangiectasia mutated (ATM), in response to exogenous DNA
damage, utilizes a SAC-associated mechanism to inhibit ana-
phase progression (42). Therefore, ATM is capable of coordi-
nating an interphaseG1/S checkpoint (43) in addition to a SAC/
CDC20-associated mitotic checkpoint. The ability of EDD to
associate with two proteins intimately associated with ATM
function (checkpoint kinase 2 (CHK2) (8) and ATM interactor
(ATMIN) (44)) as well as various SAC components raises the
possibility that it may act in a similar manner.
In this work, we identified the physical association of EDD
with the SAC proteins BUB3 and BUBR1 and an ability to over-
come Noc-mediated G2/M accumulation and influence the
expression key mitotic regulators. Both BUBR1 and EDD are
essential in early mammalian development, with homozygous
Ubr5 (45) (EDD’s murine homolog) and BUBR1 (46) null
mutants exhibiting extensive apoptosis and embryonic lethality
around embryonic days 8.5–9.5. These results, combined with
those indicating a role in suppressing DDRs (40, 41), further
implicate EDD as a potential caretaker of genomic integrity
through its ability to regulate both prophase and interphase cell
cycle arrests in response to cellular stress.
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